Icahn Raises Stake in Amylin Pharmaceuticals, Inc. to 7.3 Percent

September 15, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LOS ANGELES, Sept 12 (Reuters) - Billionaire investor Carl Icahn has raised his stake in biotechnology company Amylin Pharmaceuticals Inc to 7.33 percent, according to documents filed on Friday with the U.S. Securities and Exchange Commission.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions